EPIDEMIOLOGICAL SITUATION OF SKIN CANCER AND MELANOMIA IN THE REPUBLIC OF KAZAKHSTAN IN 2012-2022

D. Tuleuova, G. Serikbayev, А. Kurmanalyev, Z. Pyssanova, А. Yelekbayev
{"title":"EPIDEMIOLOGICAL SITUATION OF SKIN CANCER AND MELANOMIA IN THE REPUBLIC OF KAZAKHSTAN IN 2012-2022","authors":"D. Tuleuova, G. Serikbayev, А. Kurmanalyev, Z. Pyssanova, А. Yelekbayev","doi":"10.52532/2663-4864-2024-1-71-12-21","DOIUrl":null,"url":null,"abstract":"Relevance: Skin cancer, including melanoma, is a major health problem and one of the most common cancers in the world. \nThe study aimed to obtain a complete epidemiological picture of skin cancer and melanoma in the Republic of Kazakhstan for 11 years, including analysis of data for 2022, considering various parameters such as age, sex, ethnicity, region, and tumor type. \nMethods: The study used data from patients registered in the national cancer registry of the Republic of Kazakhstan from 2012 to 2022, diagnosed with skin carcinoma and skin melanoma (ICD-10 code: C44-C43). The number of skin carcinomas and melanoma cases is presented as absolute and crude rates per 100,000 population. Absolute standardized morbidity and mortality rates were calculated using the world standard (World). \nResults: At the end of 2022, 19,714 and 2,689 patients were diagnosed with “Skin Cancer” or “Skin Melanoma” in the Republic of Kazakhstan, respectively. From 2012 to 2022, the incidence of skin cancer increased by 24% and melanoma by 15%. In 2022, the incidence of skin cancer and melanoma was higher among women by 24% and 26%, respectively. Mortality from skin cancer is in 23rd place, from melanoma in 21st place. Mortality rates from skin cancer and melanoma were 0.5 and 0.7 per 100 thousand population, respectively. The peak incidence of skin cancer in 2022 was observed in the age group 65-74 years (36%), and mortality in the age groups 65-74 and 75-84 years (17% each). The peak incidence of skin melanoma in 2022 was observed in the age groups 55-64 years and 65-74 years (24% and 25%), and mortality in the groups 45-54 years and 35-44 years (14% and 10%). \nConclusion: There has been a steady increase in the incidence of skin cancer and melanoma, which indicates the seriousness of this problem in the country and underlines the need for further measures to prevent, diagnose and treat skin cancer and melanoma in the Republic of Kazakhstan. It should be remembered that many cases of skin cancer can be prevented with simple precautions.","PeriodicalId":19480,"journal":{"name":"Oncologia i radiologia Kazakhstana","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncologia i radiologia Kazakhstana","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52532/2663-4864-2024-1-71-12-21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Relevance: Skin cancer, including melanoma, is a major health problem and one of the most common cancers in the world. The study aimed to obtain a complete epidemiological picture of skin cancer and melanoma in the Republic of Kazakhstan for 11 years, including analysis of data for 2022, considering various parameters such as age, sex, ethnicity, region, and tumor type. Methods: The study used data from patients registered in the national cancer registry of the Republic of Kazakhstan from 2012 to 2022, diagnosed with skin carcinoma and skin melanoma (ICD-10 code: C44-C43). The number of skin carcinomas and melanoma cases is presented as absolute and crude rates per 100,000 population. Absolute standardized morbidity and mortality rates were calculated using the world standard (World). Results: At the end of 2022, 19,714 and 2,689 patients were diagnosed with “Skin Cancer” or “Skin Melanoma” in the Republic of Kazakhstan, respectively. From 2012 to 2022, the incidence of skin cancer increased by 24% and melanoma by 15%. In 2022, the incidence of skin cancer and melanoma was higher among women by 24% and 26%, respectively. Mortality from skin cancer is in 23rd place, from melanoma in 21st place. Mortality rates from skin cancer and melanoma were 0.5 and 0.7 per 100 thousand population, respectively. The peak incidence of skin cancer in 2022 was observed in the age group 65-74 years (36%), and mortality in the age groups 65-74 and 75-84 years (17% each). The peak incidence of skin melanoma in 2022 was observed in the age groups 55-64 years and 65-74 years (24% and 25%), and mortality in the groups 45-54 years and 35-44 years (14% and 10%). Conclusion: There has been a steady increase in the incidence of skin cancer and melanoma, which indicates the seriousness of this problem in the country and underlines the need for further measures to prevent, diagnose and treat skin cancer and melanoma in the Republic of Kazakhstan. It should be remembered that many cases of skin cancer can be prevented with simple precautions.
2012-2022 年哈萨克斯坦共和国皮肤癌和黑色素瘤的流行病学状况
相关性:包括黑色素瘤在内的皮肤癌是一个重大健康问题,也是世界上最常见的癌症之一。本研究旨在全面了解哈萨克斯坦共和国 11 年来皮肤癌和黑色素瘤的流行病学情况,包括分析 2022 年的数据,并考虑年龄、性别、种族、地区和肿瘤类型等各种参数。研究方法研究使用的数据来自哈萨克斯坦共和国国家癌症登记处2012年至2022年登记的确诊为皮肤癌和皮肤黑色素瘤(ICD-10代码:C44-C43)的患者。皮肤癌和黑色素瘤病例数以每十万人的绝对比率和粗比率表示。绝对标准化发病率和死亡率采用世界标准(World)计算。结果:截至2022年底,哈萨克斯坦共和国分别有19714名和2689名患者被诊断为 "皮肤癌 "或 "皮肤黑色素瘤"。从 2012 年到 2022 年,皮肤癌发病率增加了 24%,黑色素瘤发病率增加了 15%。2022 年,妇女的皮肤癌和黑色素瘤发病率分别增加了 24%和 26%。皮肤癌死亡率排名第 23 位,黑色素瘤死亡率排名第 21 位。皮肤癌和黑色素瘤的死亡率分别为每 10 万人 0.5 例和 0.7 例。2022 年,皮肤癌的发病高峰出现在 65-74 岁年龄组(36%),死亡率则出现在 65-74 岁和 75-84 岁年龄组(各占 17%)。2022 年,皮肤黑色素瘤的发病高峰出现在 55-64 岁和 65-74 岁年龄组(分别为 24% 和 25%),死亡率则出现在 45-54 岁和 35-44 岁年龄组(分别为 14% 和 10%)。结论皮肤癌和黑色素瘤的发病率持续上升,这表明我国这一问题的严重性,并强调哈萨克斯坦共和国需要采取进一步措施预防、诊断和治疗皮肤癌和黑色素瘤。应当记住,许多皮肤癌病例可以通过简单的预防措施加以预防。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信